VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot C5916AA: VAERS reports

30 VAERS reports list lot C5916AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2021-10-09 and 2023-08-08. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
30
Reports
0%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1354%
Neurological312%
General / Systemic (non-local)312%
Allergic / Anaphylactic28%
Gastrointestinal14%
Dermatological (non-injection-site)14%
Psychiatric / Neuropsychiatric14%

Where reports came from

U.S. state of the reporter, where given (top 12).

Indiana6
New York5
Michigan3
Pennsylvania2
Texas2
Minnesota2
Kansas2
Vermont1
West Virginia1
Alabama1
Oregon1
California1

Reports by month received

2021-101
2022-011
2022-034
2022-041
2022-054
2022-061
2022-081
2022-092
2022-101
2022-111
2023-012
2023-051
2023-062
2023-077
2023-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.